Related Experiment Video
Updated: Oct 2, 2025

Excitotoxic Stimulation of Brain Microslices as an In vitro Model of Stroke
Published on: February 4, 2014
CADASIL mutations sensitize the brain to ischemia via spreading depolarizations and abnormal extracellular potassium
Fumiaki Oka1,2, Jeong Hyun Lee1,3, Izumi Yuzawa1
1Neurovascular Research Unit, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Abstract:
Cerebral autosomal dominant arteriopathy, subcortical infarcts, and leukoencephalopathy (CADASIL) is the most common monogenic form of small vessel disease characterized by migraine with aura, leukoaraiosis, strokes, and dementia. CADASIL mutations cause cerebrovascular dysfunction in both animal models and humans. Here, we showed that 2 different human CADASIL mutations (Notch3 R90C or R169C) worsen ischemic stroke outcomes in transgenic mice; this was explained by the higher blood flow threshold to maintain tissue viability compared with that in wild type (WT) mice. Both mutants developed larger infarcts and worse neurological deficits compared with WT mice, regardless of age or sex after filament middle cerebral artery occlusion. However, full-field laser speckle flowmetry during distal middle cerebral artery occlusion showed comparable perfusion deficits in mutants and their respective WT controls. Circle of Willis anatomy and pial collateralization also did not differ among the genotypes. In contrast, mutants had a higher cerebral blood flow threshold, below which infarction ensued, suggesting increased sensitivity of brain tissue to ischemia. Electrophysiological recordings revealed a 1.5- to 2-fold higher frequency of peri-infarct spreading depolarizations in CADASIL mutants. Higher extracellular K+ elevations during spreading depolarizations in the mutants implicated a defect in extracellular K+ clearance. Altogether, these data reveal a mechanism of enhanced vulnerability to ischemic injury linked to abnormal extracellular ion homeostasis and susceptibility to ischemic depolarizations in CADASIL.
Insights
Cerebral autosomal dominant arteriopathy, subcortical infarcts, and leukoencephalopathy (CADASIL) mutations increase stroke severity in mice by impairing brain tissue
Area of Science:
- Neuroscience
- Genetics
- Vascular Biology
Background:
- Cerebral autosomal dominant arteriopathy, subcortical infarcts, and leukoencephalopathy (CADASIL) is a genetic small vessel disease.
- CADASIL is characterized by stroke, dementia, and migraine with aura, linked to Notch3 mutations.
- CADASIL mutations are known to cause cerebrovascular dysfunction.
Purpose of the Study:
- To investigate the impact of specific CADASIL mutations on ischemic stroke outcomes in a mouse model.
- To elucidate the underlying mechanisms contributing to increased stroke vulnerability in CADASIL.
Main Methods:
- Utilized transgenic mouse models carrying human CADASIL Notch3 mutations (R90C, R169C).
- Induced ischemic stroke using filament middle cerebral artery occlusion.
- Assessed infarct volume, neurological deficits, cerebral blood flow, and electrophysiological properties (spreading depolarizations).
Main Results:
- CADASIL mutant mice exhibited larger infarcts and worse neurological deficits post-stroke compared to wild-type mice.
- Mutants displayed a higher threshold of cerebral blood flow required to maintain tissue viability, indicating increased ischemic sensitivity.
- Increased frequency of peri-infarct spreading depolarizations and elevated extracellular K+ were observed in mutants, suggesting impaired K+ clearance.
Conclusions:
- Human CADASIL mutations exacerbate ischemic stroke outcomes by increasing brain tissue sensitivity to ischemia.
- Impaired extracellular ion homeostasis and heightened susceptibility to spreading depolarizations contribute to stroke vulnerability in CADASIL.
- These findings reveal a novel mechanism of enhanced ischemic injury in CADASIL, linked to ion dysregulation.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...

